Paper Review Records
All Paper Review Records
12 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
16
days
Distinctive megakaryocytic atypia in VEXAS syndrome
Authors
Yingdong Xu; Wei Fu; Pingping WangShow moreShow less
Affiliations
1. Department of Hematology, The First Hospital of China Medical University, Shenyang, ChinaShow moreShow less
58
days
HHV8-associated multicentric Castleman disease with Kaposi sarcoma in an immunocompetent patient: a case report and review of the literature
Authors
K. Hoerschgen; W. Zhang; A. Rappolt; A. Ashford; J. C. Padussis; J. D. Khoury; A. RonaghyShow moreShow less
Affiliations
1. Department of Pathology, Microbiology, and Immunology, University of Nebraska Medical Center, Omaha, USA; 2. Department of Internal Medicine, University of Nebraska Medical Center, Omaha, USA; 3. Department of Surgery, Division of Surgical Oncology, University of Nebraska Medical Center, Omaha, USAShow moreShow less
85
days
Myeloid neoplasm with PDGFRA rearrangement presenting in blast-phase with basophilia
Authors
Anne-Cecilia van Marle; Evan BowenShow moreShow less
Affiliations
1. Department of Haematology and Cell Biology, School of Pathology, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa; 2. Department of Haematology and Cell Biology, Universitas Academic Hospital Laboratory, National Health Laboratory Service, Bloemfontein, South AfricaShow moreShow less
29
days
Histiocytoid melanoma presenting as lymphadenopathy and mimicking Rosai–Dorfman disease
Authors
Stephen J. Babcock; Valentina NardiShow moreShow less
Affiliations
1. Department of Pathology, Mass General Brigham, Harvard Medical School, Boston, USA; 2. Massachusetts General Hospital, Boston, USAShow moreShow less
136
days
EBV-positive Hodgkin lymphoma with an immunosuppressive microenvironment during guselkumab (interleukin-23 inhibitor) therapy for chronic plaque psoriasis
Authors
Bhaumik Shah; Janusz Franco-Barraza; Kathy Q. Cai; Mariia Dmitrieva; Marcus Messmer; Yibin Yang; Mariusz Wasik; Edna Cukierman; Reza NejatiShow moreShow less
Affiliations
1. Department of Pathology, Fox Chase Cancer Center, Temple Health, Philadelphia, USA; 2. Cancer Signaling & Microenvironment Program, Fox Chase Cancer Center, Temple Health, Philadelphia, USA; 3. Department of Hematology/Oncology, Fox Chase Cancer Center, Temple Health, Philadelphia, USAShow moreShow less
57
days
Early-onset VEXAS syndrome mimicking orbital cellulitis and successfully treated with allogeneic hematopoietic stem cell transplantation
Authors
Gökhan Burul; Çagla Karaoglan; Erdem Bektaş; Cemal Bes; Leylagül Kaynar; İstemi Serin; Şeniz ÖngörenShow moreShow less
Affiliations
1. Department of Hematology, İstanbul Başakşehir Çam and Sakura City Hospital, Basaksehir, Turkey; 2. Department of Pathology, İstanbul Başakşehir Çam and Sakura City Hospital, Istanbul, Turkey; 3. Department of Rheumatology, İstanbul Başakşehir Çam and Sakura City Hospital, Istanbul, Turkey; 4. Department of Hematology, Medipol University, Istanbul, TurkeyShow moreShow less
FAQ
How long does Journal of Hematopathology take to review a manuscript?
As of 2026-11-19, CrushSCI has 12 complete review records for Journal of Hematopathology. The fastest paper went from submission to acceptance in 16 days (Distinctive megakaryocytic atypia in VEXAS syndrome, received 2026-10-26, accepted 2026-11-11); the slowest took 223 days. The average is 95 days and the median is 75.5 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
